Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khuri

Showing results (901-910 of 969) with videos related to

Pageof 97
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLCRathi N Pillai, Seth A Brodie, Gabriel L Sica, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2016
National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung CancerKristin A Higgins, Kelli O'Connell, Yuan Liu, et al.
Journal of the National Cancer Institute|April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patientsFadlo R Khuri, J Jack Lee, Scott M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Fenretinide activity in retinoid-resistant oral leukoplakiaScott M Lippman, J Jack Lee, Jack W Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancerF Christopher Holsinger, Merrill S Kies, Eduardo M Diaz, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|April 26, 2012
Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenograftsShijun Zhu, Terry W Moore, Xiaoqian Lin, et al.
Seminars in Radiation Oncology|March 28, 2002
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary resultsR Komaki, J S Lee, B Kaplan, et al.
Head and Neck Pathology|July 25, 2013
Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neckNabil F Saba, Kelly R Magliocca, Sungjin Kim, et al.
Head & Neck|March 6, 2019
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysisAmr Mohamed, Brandon Twardy, Magdi A Zordok, et al.
Journal of the American College of Surgeons|February 3, 2009
Surgical site infection prevention: the importance of operative duration and blood transfusion--results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices InitiativeDarrell A Campbell, William G Henderson, Michael J Englesbe, et al.
Pageof 97

Showing results (901-910 of 969) with videos related to

Sort By:
Pageof 97
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLCRathi N Pillai, Seth A Brodie, Gabriel L Sica, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2016
National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung CancerKristin A Higgins, Kelli O'Connell, Yuan Liu, et al.
Journal of the National Cancer Institute|April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patientsFadlo R Khuri, J Jack Lee, Scott M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Fenretinide activity in retinoid-resistant oral leukoplakiaScott M Lippman, J Jack Lee, Jack W Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancerF Christopher Holsinger, Merrill S Kies, Eduardo M Diaz, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|April 26, 2012
Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenograftsShijun Zhu, Terry W Moore, Xiaoqian Lin, et al.
Seminars in Radiation Oncology|March 28, 2002
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary resultsR Komaki, J S Lee, B Kaplan, et al.
Head and Neck Pathology|July 25, 2013
Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neckNabil F Saba, Kelly R Magliocca, Sungjin Kim, et al.
Head & Neck|March 6, 2019
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysisAmr Mohamed, Brandon Twardy, Magdi A Zordok, et al.
Journal of the American College of Surgeons|February 3, 2009
Surgical site infection prevention: the importance of operative duration and blood transfusion--results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices InitiativeDarrell A Campbell, William G Henderson, Michael J Englesbe, et al.
Pageof 97